Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion [Phase 3]

View source ↗

Summary

Phase 3 results evaluate Faricimab for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. The trial status is completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion
• Hemiretinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Macular Edema, Central Retinal Vein Occlusion | Phase 3 | Status: COMPLETED | Results posted: 2024-01-18